AI assistant
SURMODICS INC — Director's Dealing 2019
Jan 4, 2019
32845_dirs_2019-01-04_df2af8a9-da2c-4c52-9b45-0a6d2c929b1b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-01-02
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-02 | Common Stock | S | 4900 | $46.2045 | Disposed | 174967 | Direct |
| 2019-01-02 | Common Stock | S | 100 | $46.83 | Disposed | 174867 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
F2: Reflects the weighted average price of 4,900 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on January 2, 2019 with sale prices ranging from $45.76 to $46.67 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.